查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1742554

药物洗脱支架市场－全球产业分析、规模、份额、成长、趋势及预测（2025-2035）

Drug-Eluting Stents Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035
出版日期: | 出版商: Transparency Market Research | 英文 205 Pages | 商品交期: 2-10个工作天内

价格

药物洗脱支架市场-报告范围

TMR 的全球药物洗脱支架市场报告研究了过去和当前的成长趋势及机会，旨在深入了解 2025 年至 2035 年预测期内的市场指标。该报告提供了 2019 年至 2035 年期间全球药物洗脱支架市场的收入，以 2025 年为基准年，2035 年为预测年。该报告还提供了 2025 年至 2035 年全球药物洗脱支架市场的年复合成长率(CAGR%)。

本报告经过广泛的调查后编写。主要研究工作包括分析师对关键意见领袖、产业领袖和舆论领袖的访谈。次要研究则参考了主要参与者的产品资料、年度报告、新闻稿和相关文件，以了解药物洗脱支架市场。

市场概况
2024 年的市场价值 77亿美元
2035年的市场价值 142亿美元
复合年增长率 5.7%

本报告深入探讨了全球药物洗脱支架市场的竞争格局。报告确定了全球药物洗脱支架市场的主要参与者，并根据其各项属性进行了分析。本报告对全球药物洗脱支架市场参与者的属性进行了分析，内容包括公司概况、财务状况、近期发展和 SWOT 分析。

目录

第一章：前言

第二章：假设与研究方法

第三章：执行摘要：全球市场

第四章：市场概览

  • 介绍
  • 概述
  • 市场动态
  • 2020-2035年全球药物洗脱支架市场分析与预测

第五章：关键见解

  • 技术进步
  • 波特五力分析
  • PESTEL分析
  • 供应链分析
  • 重要产业事件（合併、收购、合作、协作等）
  • 定价分析（品牌定价、按地区/国家分類的平均售价）
  • 各主要国家的监管情况
  • 研发趋势
  • 新市场进入者的市场进入策略

第六章：全球市场分析与预测：依材料

  • 介绍与定义
  • 主要发现/进展
  • 市场价值预测：按材料，2020-2035
    • 金属
      • 不銹钢
      • 钴铬合金
      • 镍钛合金
      • 其他的
    • 聚合物
      • 非生物分解的聚合物
      • 可生物降解聚合物
  • 市场吸引力分析：按材料

第七章：全球市场分析与预测：按药物

  • 介绍与定义
  • 主要发现/进展
  • 市场价值预测：按药物，2020-2035
    • 雷帕霉素
    • 紫杉醇
    • 佐他莫司
    • 依维莫司
    • 其他的
  • 市场吸引力分析：按药物

第八章：全球市场分析与预测：按应用

  • 介绍与定义
  • 主要发现/进展
  • 市场价值预测：按应用，2020-2035
    • 冠状动脉疾病
    • 週边动脉疾病
    • 其他的
  • 市场吸引力分析：按应用

第九章：全球市场分析与预测：按最终用户

  • 介绍和定义
  • 主要发现/进展
  • 市场价值预测：按最终用户，2020-2035
    • 医院
    • 门诊手术中心
    • 其他的
  • 市场吸引力分析：按最终用户

第十章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区，2020-2035
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 各地区市场吸引力

第 11 章：北美市场分析与预测

第十二章：欧洲市场分析与预测

第十四章：拉丁美洲市场分析与预测

第十五章：中东与非洲市场分析与预测

第 16 章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 市占率分析：按公司（2024年）
  • 公司简介
    • Abbott Laboratories
    • AlviMedica
    • B. Braun Melsungen AG
    • Biosensors International Group, Ltd.
    • Shandong JW Medical Systems LTD.
    • Boston Scientific Corporation
    • Cook Medical Inc.
    • Elixir Medical Corp.
    • Lepu Medical Technology (Beijing) Co., Ltd.
    • Medtronic plc
    • Eurocor GmbH
    • OrbusNeich Medical Company Limited
    • Shanghai MicroPort Medical Co., Ltd.
    • Sino Medical Sciences Technology Inc.
Product Code: TMRGL30632

Drug-Eluting Stents Market - Scope of Report

TMR's report on the global drug-eluting stents market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global drug-eluting stents market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global drug-eluting stents market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the drug-eluting stents market.

Market Snapshot
Market Value in 2024US$ 7.7 Bn
Market Value in 2035US$ 14.2 Bn
CAGR5.7%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global drug-eluting stents market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global drug-eluting stents market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global drug-eluting stents market.

The report delves into the competitive landscape of the global drug-eluting stents market. Key players operating in the global drug-eluting stents market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global drug-eluting stents market profiled in this report.

Key Questions Answered in global drug-eluting stents Market Report:

  • What is the sales/revenue generated by drug-eluting stents across all regions during the forecast period?
  • What are the opportunities in the global drug-eluting stents market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Drug-Eluting Stents Market - Research Objectives and Research Approach

The comprehensive report on the global drug-eluting stents market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global drug-eluting stents market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global drug-eluting stents market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Drug-Eluting Stents Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Drug-Eluting Stents Market Analysis and Forecast, 2020-2035
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Technological Advancements
  • 5.2. PORTER's Five Forces Analysis
  • 5.3. PESTEL Analysis
  • 5.4. Supply Chain Analysis
  • 5.5. Key Industry Events (Mergers, Acquisitions, Partnerships, Collaborations, etc.)
  • 5.6. Pricing Analysis (Brand pricing, Average Selling Price by Region/Country)
  • 5.7. Regulatory Scenario by Key Country/Region
  • 5.8. Research and Development Trends
  • 5.9. Go-to-Market Strategy for New Market Entrants

6. Global Drug-Eluting Stents Market Analysis and Forecast, by Material

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Material, 2020-2035
    • 6.3.1. Metal
      • 6.3.1.1. Stainless-Steel
      • 6.3.1.2. Cobalt-Chromium
      • 6.3.1.3. Nitinol
      • 6.3.1.4. Others
    • 6.3.2. Polymer
      • 6.3.2.1. Non-biodegradable Polymers
      • 6.3.2.2. Biodegradable Polymers
  • 6.4. Market Attractiveness Analysis, by Material

7. Global Drug-Eluting Stents Market Analysis and Forecast, by Drug

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Drug, 2020-2035
    • 7.3.1. Sirolimus
    • 7.3.2. Paclitaxel
    • 7.3.3. Zotarolimus
    • 7.3.4. Everolimus
    • 7.3.5. Others
  • 7.4. Market Attractiveness Analysis, by Drug

8. Global Drug-Eluting Stents Market Analysis and Forecast, by Application

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Application , 2020-2035
    • 8.3.1. Coronary Artery Disease
    • 8.3.2. Peripheral Artery Disease
    • 8.3.3. Others
  • 8.4. Market Attractiveness Analysis, by Application

9. Global Drug-Eluting Stents Market Analysis and Forecast, by End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by End-user, 2020-2035
    • 9.3.1. Hospitals
    • 9.3.2. Ambulatory Surgical Centers
    • 9.3.3. Others
  • 9.4. Market Attractiveness Analysis, by End-user

10. Global Drug-Eluting Stents Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2020-2035
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness By Region

11. North America Drug-Eluting Stents Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Material, 2020-2035
    • 11.2.1. Metal
      • 11.2.1.1. Stainless-Steel
      • 11.2.1.2. Cobalt-Chromium
      • 11.2.1.3. Nitinol
      • 11.2.1.4. Others
    • 11.2.2. Polymer
      • 11.2.2.1. Non-biodegradable Polymers
      • 11.2.2.2. Biodegradable Polymers
  • 11.3. Market Value Forecast, by Drug, 2020-2035
    • 11.3.1. Sirolimus
    • 11.3.2. Paclitaxel
    • 11.3.3. Zotarolimus
    • 11.3.4. Everolimus
    • 11.3.5. Others
  • 11.4. Market Value Forecast, by Application , 2020-2035
    • 11.4.1. Coronary Artery Disease
    • 11.4.2. Peripheral Artery Disease
    • 11.4.3. Others
  • 11.5. Market Value Forecast, by End-user, 2020-2035
    • 11.5.1. Hospitals
    • 11.5.2. Ambulatory Surgical Centers
    • 11.5.3. Others
  • 11.6. Market Value Forecast, by Country, 2020-2035
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Material
    • 11.7.2. By Drug
    • 11.7.3. By Application
    • 11.7.4. By End-user
    • 11.7.5. By Country

12. Europe Drug-Eluting Stents Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Material, 2020-2035
    • 12.2.1. Metal
      • 12.2.1.1. Stainless-Steel
      • 12.2.1.2. Cobalt-Chromium
      • 12.2.1.3. Nitinol
      • 12.2.1.4. Others
    • 12.2.2. Polymer
      • 12.2.2.1. Non-biodegradable Polymers
      • 12.2.2.2. Biodegradable Polymers
  • 12.3. Market Value Forecast, by Drug, 2020-2035
    • 12.3.1. Sirolimus
    • 12.3.2. Paclitaxel
    • 12.3.3. Zotarolimus
    • 12.3.4. Everolimus
    • 12.3.5. Others
  • 12.4. Market Value Forecast, by Application , 2020-2035
    • 12.4.1. Coronary Artery Disease
    • 12.4.2. Peripheral Artery Disease
    • 12.4.3. Others
  • 12.5. Market Value Forecast, by End-user, 2020-2035
    • 12.5.1. Hospitals
    • 12.5.2. Ambulatory Surgical Centers
    • 12.5.3. Others
  • 12.6. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 12.6.1. Germany
    • 12.6.2. UK
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Material
    • 12.7.2. By Drug
    • 12.7.3. By Application
    • 12.7.4. By End-user
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Drug-Eluting Stents Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Material, 2020-2035
    • 13.2.1. Metal
      • 13.2.1.1. Stainless-Steel
      • 13.2.1.2. Cobalt-Chromium
      • 13.2.1.3. Nitinol
      • 13.2.1.4. Others
    • 13.2.2. Polymer
      • 13.2.2.1. Non-biodegradable Polymers
      • 13.2.2.2. Biodegradable Polymers
  • 13.3. Market Value Forecast, by Drug, 2020-2035
    • 13.3.1. Sirolimus
    • 13.3.2. Paclitaxel
    • 13.3.3. Zotarolimus
    • 13.3.4. Everolimus
    • 13.3.5. Others
  • 13.4. Market Value Forecast, by Application , 2020-2035
    • 13.4.1. Coronary Artery Disease
    • 13.4.2. Peripheral Artery Disease
    • 13.4.3. Others
  • 13.5. Market Value Forecast, by End-user, 2020-2035
    • 13.5.1. Hospitals
    • 13.5.2. Ambulatory Surgical Centers
    • 13.5.3. Others
  • 13.6. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Material
    • 13.7.2. By Drug
    • 13.7.3. By Application
    • 13.7.4. By End-user
    • 13.7.5. By Country/Sub-region

14. Latin America Drug-Eluting Stents Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Material, 2020-2035
    • 14.2.1. Metal
      • 14.2.1.1. Stainless-Steel
      • 14.2.1.2. Cobalt-Chromium
      • 14.2.1.3. Nitinol
      • 14.2.1.4. Others
    • 14.2.2. Polymer
      • 14.2.2.1. Non-biodegradable Polymers
      • 14.2.2.2. Biodegradable Polymers
  • 14.3. Market Value Forecast, by Drug, 2020-2035
    • 14.3.1. Sirolimus
    • 14.3.2. Paclitaxel
    • 14.3.3. Zotarolimus
    • 14.3.4. Everolimus
    • 14.3.5. Others
  • 14.4. Market Value Forecast, by Application , 2020-2035
    • 14.4.1. Coronary Artery Disease
    • 14.4.2. Peripheral Artery Disease
    • 14.4.3. Others
  • 14.5. Market Value Forecast, by End-user, 2020-2035
    • 14.5.1. Hospitals
    • 14.5.2. Ambulatory Surgical Centers
    • 14.5.3. Others
  • 14.6. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Material
    • 14.7.2. By Drug
    • 14.7.3. By Application
    • 14.7.4. By End-user
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Drug-Eluting Stents Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Material, 2020-2035
    • 15.2.1. Metal
      • 15.2.1.1. Stainless-Steel
      • 15.2.1.2. Cobalt-Chromium
      • 15.2.1.3. Nitinol
      • 15.2.1.4. Others
    • 15.2.2. Polymer
      • 15.2.2.1. Non-biodegradable Polymers
      • 15.2.2.2. Biodegradable Polymers
  • 15.3. Market Value Forecast, by Drug, 2020-2035
    • 15.3.1. Sirolimus
    • 15.3.2. Paclitaxel
    • 15.3.3. Zotarolimus
    • 15.3.4. Everolimus
    • 15.3.5. Others
  • 15.4. Market Value Forecast, by Application , 2020-2035
    • 15.4.1. Coronary Artery Disease
    • 15.4.2. Peripheral Artery Disease
    • 15.4.3. Others
  • 15.5. Market Value Forecast, by End-user, 2020-2035
    • 15.5.1. Hospitals
    • 15.5.2. Ambulatory Surgical Centers
    • 15.5.3. Others
  • 15.6. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Material
    • 15.7.2. By Drug
    • 15.7.3. By Application
    • 15.7.4. By End-user
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 16.2. Market Share Analysis, by Company (2024)
  • 16.3. Company Profiles
    • 16.3.1. Abbott Laboratories
      • 16.3.1.1. Company Overview
      • 16.3.1.2. Financial Overview
      • 16.3.1.3. Product Portfolio
      • 16.3.1.4. Business Strategies
      • 16.3.1.5. Recent Developments
    • 16.3.2. AlviMedica
      • 16.3.2.1. Company Overview
      • 16.3.2.2. Financial Overview
      • 16.3.2.3. Product Portfolio
      • 16.3.2.4. Business Strategies
      • 16.3.2.5. Recent Developments
    • 16.3.3. B. Braun Melsungen AG
      • 16.3.3.1. Company Overview
      • 16.3.3.2. Financial Overview
      • 16.3.3.3. Product Portfolio
      • 16.3.3.4. Business Strategies
      • 16.3.3.5. Recent Developments
    • 16.3.4. Biosensors International Group, Ltd.
      • 16.3.4.1. Company Overview
      • 16.3.4.2. Financial Overview
      • 16.3.4.3. Product Portfolio
      • 16.3.4.4. Business Strategies
      • 16.3.4.5. Recent Developments
    • 16.3.5. Shandong JW Medical Systems LTD.
      • 16.3.5.1. Company Overview
      • 16.3.5.2. Financial Overview
      • 16.3.5.3. Product Portfolio
      • 16.3.5.4. Business Strategies
      • 16.3.5.5. Recent Developments
    • 16.3.6. Boston Scientific Corporation
      • 16.3.6.1. Company Overview
      • 16.3.6.2. Financial Overview
      • 16.3.6.3. Product Portfolio
      • 16.3.6.4. Business Strategies
      • 16.3.6.5. Recent Developments
    • 16.3.7. Cook Medical Inc.
      • 16.3.7.1. Company Overview
      • 16.3.7.2. Financial Overview
      • 16.3.7.3. Product Portfolio
      • 16.3.7.4. Business Strategies
      • 16.3.7.5. Recent Developments
    • 16.3.8. Elixir Medical Corp.
      • 16.3.8.1. Company Overview
      • 16.3.8.2. Financial Overview
      • 16.3.8.3. Product Portfolio
      • 16.3.8.4. Business Strategies
      • 16.3.8.5. Recent Developments
    • 16.3.9. Lepu Medical Technology (Beijing) Co., Ltd.
      • 16.3.9.1. Company Overview
      • 16.3.9.2. Financial Overview
      • 16.3.9.3. Product Portfolio
      • 16.3.9.4. Business Strategies
      • 16.3.9.5. Recent Developments
    • 16.3.10. Medtronic plc
      • 16.3.10.1. Company Overview
      • 16.3.10.2. Financial Overview
      • 16.3.10.3. Product Portfolio
      • 16.3.10.4. Business Strategies
      • 16.3.10.5. Recent Developments
    • 16.3.11. Eurocor GmbH
      • 16.3.11.1. Company Overview
      • 16.3.11.2. Financial Overview
      • 16.3.11.3. Product Portfolio
      • 16.3.11.4. Business Strategies
      • 16.3.11.5. Recent Developments
    • 16.3.12. OrbusNeich Medical Company Limited
      • 16.3.12.1. Company Overview
      • 16.3.12.2. Financial Overview
      • 16.3.12.3. Product Portfolio
      • 16.3.12.4. Business Strategies
      • 16.3.12.5. Recent Developments
    • 16.3.13. Shanghai MicroPort Medical Co., Ltd.
      • 16.3.13.1. Company Overview
      • 16.3.13.2. Financial Overview
      • 16.3.13.3. Product Portfolio
      • 16.3.13.4. Business Strategies
      • 16.3.13.5. Recent Developments
    • 16.3.14. Sino Medical Sciences Technology Inc.
      • 16.3.14.1. Company Overview
      • 16.3.14.2. Financial Overview
      • 16.3.14.3. Product Portfolio
      • 16.3.14.4. Business Strategies
      • 16.3.14.5. Recent Developments

List of Tables

  • Table 01: Global Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Material, 2020-2035
  • Table 02: Global Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Metal, 2020-2035
  • Table 03: Global Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Polymer, 2020-2035
  • Table 04: Global Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Drug, 2020-2035
  • Table 05: Global Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Application, 2020-2035
  • Table 06: Global Drug-Eluting Stents Market Value (US$ Bn) Forecast, By End-user, 2020-2035
  • Table 07: Global Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Region, 2020-2035
  • Table 08: North America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, by Country, 2020-2035
  • Table 09: North America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Material, 2020-2035
  • Table 10: North America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Metal, 2020-2035
  • Table 11: North America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Polymer, 2020-2035
  • Table 12: North America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Drug, 2020-2035
  • Table 13: North America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Application, 2020-2035
  • Table 14: North America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By End-user, 2020-2035
  • Table 15: Europe - Drug-Eluting Stents Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 16: Europe - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Material, 2020-2035
  • Table 17: Europe - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Metal, 2020-2035
  • Table 18: Europe - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Polymer, 2020-2035
  • Table 19: Europe - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Drug, 2020-2035
  • Table 20: Europe - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Application, 2020-2035
  • Table 21: Europe - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By End-user, 2020-2035
  • Table 22: Asia Pacific - Drug-Eluting Stents Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 23: Asia Pacific - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Material, 2020-2035
  • Table 24: Asia Pacific - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Metal, 2020-2035
  • Table 25: Asia Pacific - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Polymer, 2020-2035
  • Table 26: Asia Pacific - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Drug, 2020-2035
  • Table 27: Asia Pacific - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Application, 2020-2035
  • Table 28: Asia Pacific - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By End-user, 2020-2035
  • Table 29: Latin America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 30: Latin America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Material, 2020-2035
  • Table 31: Latin America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Metal, 2020-2035
  • Table 32: Latin America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Polymer, 2020-2035
  • Table 33: Latin America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Drug, 2020-2035
  • Table 34: Latin America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Application, 2020-2035
  • Table 35: Latin America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By End-user, 2020-2035
  • Table 36: Middle East & Africa - Drug-Eluting Stents Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
  • Table 37: Middle East & Africa - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Material, 2020-2035
  • Table 38: Middle East & Africa - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Metal, 2020-2035
  • Table 39: Middle East & Africa - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Polymer, 2020-2035
  • Table 40: Middle East & Africa - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Drug, 2020-2035
  • Table 41: Middle East & Africa - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Application, 2020-2035
  • Table 42: Middle East & Africa - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By End-user, 2020-2035

List of Figures

  • Figure 01: Global Drug-Eluting Stents Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 02: Global Drug-Eluting Stents Market Value Share Analysis, By Material, 2024 and 2035
  • Figure 03: Global Drug-Eluting Stents Market Attractiveness Analysis, By Material, 2025-2035
  • Figure 04: Global Drug-Eluting Stents Market Revenue (US$ Bn), by Polymer, 2020-2035
  • Figure 05: Global Drug-Eluting Stents Market Revenue (US$ Bn), by Metal, 2020-2035
  • Figure 06: Global Drug-Eluting Stents Market Value Share Analysis, By Drug, 2024 and 2035
  • Figure 07: Global Drug-Eluting Stents Market Attractiveness Analysis, By Drug, 2025-2035
  • Figure 08: Global Drug-Eluting Stents Market Revenue (US$ Bn), by Sirolimus, 2020-2035
  • Figure 09: Global Drug-Eluting Stents Market Revenue (US$ Bn), by Paclitaxel, 2020-2035
  • Figure 10: Global Drug-Eluting Stents Market Revenue (US$ Bn), by Zotarolimus, 2020-2035
  • Figure 11: Global Drug-Eluting Stents Market Revenue (US$ Bn), by Everolimus, 2020-2035
  • Figure 12: Global Drug-Eluting Stents Market Revenue (US$ Bn), by Others, 2020-2035
  • Figure 13: Global Drug-Eluting Stents Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 14: Global Drug-Eluting Stents Market Attractiveness Analysis, By Application, 2025-2035
  • Figure 15: Global Drug-Eluting Stents Market Revenue (US$ Bn), by Coronary Artery Disease, 2020-2035
  • Figure 16: Global Drug-Eluting Stents Market Revenue (US$ Bn), by Peripheral Artery Disease, 2020-2035
  • Figure 17: Global Drug-Eluting Stents Market Revenue (US$ Bn), by Others, 2020-2035
  • Figure 18: Global Drug-Eluting Stents Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 19: Global Drug-Eluting Stents Market Attractiveness Analysis, By End-user, 2025-2035
  • Figure 20: Global Drug-Eluting Stents Market Revenue (US$ Bn), by Hospital, 2020-2035
  • Figure 21: Global Drug-Eluting Stents Market Revenue (US$ Bn), by Ambulatory Surgical Centers, 2020-2035
  • Figure 22: Global Drug-Eluting Stents Market Revenue (US$ Bn), by Others, 2020-2035
  • Figure 23: Global Drug-Eluting Stents Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 24: Global Drug-Eluting Stents Market Attractiveness Analysis, By Region, 2025-2035
  • Figure 25: North America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 26: North America - Drug-Eluting Stents Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 27: North America - Drug-Eluting Stents Market Attractiveness Analysis, by Country, 2025-2035
  • Figure 28: North America - Drug-Eluting Stents Market Value Share Analysis, By Material, 2024 and 2035
  • Figure 29: North America - Drug-Eluting Stents Market Attractiveness Analysis, By Material, 2025-2035
  • Figure 30: North America - Drug-Eluting Stents Market Value Share Analysis, By Drug, 2024 and 2035
  • Figure 31: North America - Drug-Eluting Stents Market Attractiveness Analysis, By Drug, 2025-2035
  • Figure 32: North America - Drug-Eluting Stents Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 33: North America - Drug-Eluting Stents Market Attractiveness Analysis, By Application, 2025-2035
  • Figure 34: North America - Drug-Eluting Stents Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 35: North America - Drug-Eluting Stents Market Attractiveness Analysis, By End-user, 2025-2035
  • Figure 36: Europe - Drug-Eluting Stents Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 37: Europe - Drug-Eluting Stents Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 38: Europe - Drug-Eluting Stents Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 39: Europe - Drug-Eluting Stents Market Value Share Analysis, By Material, 2024 and 2035
  • Figure 40: Europe - Drug-Eluting Stents Market Attractiveness Analysis, By Material, 2025-2035
  • Figure 41: Europe - Drug-Eluting Stents Market Value Share Analysis, By Drug, 2024 and 2035
  • Figure 42: Europe - Drug-Eluting Stents Market Attractiveness Analysis, By Drug, 2025-2035
  • Figure 43: Europe - Drug-Eluting Stents Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 44: Europe - Drug-Eluting Stents Market Attractiveness Analysis, By Application, 2025-2035
  • Figure 45: Europe - Drug-Eluting Stents Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 46: Europe - Drug-Eluting Stents Market Attractiveness Analysis, By End-user, 2025-2035
  • Figure 47: Asia Pacific - Drug-Eluting Stents Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 48: Asia Pacific - Drug-Eluting Stents Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 49: Asia Pacific - Drug-Eluting Stents Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
  • Figure 50: Asia Pacific - Drug-Eluting Stents Market Value Share Analysis, By Material, 2024 and 2035
  • Figure 51: Asia Pacific - Drug-Eluting Stents Market Attractiveness Analysis, By Material, 2025-2035
  • Figure 52: Asia Pacific - Drug-Eluting Stents Market Value Share Analysis, By Drug, 2024 and 2035
  • Figure 53: Asia Pacific - Drug-Eluting Stents Market Attractiveness Analysis, By Drug, 2025-2035
  • Figure 54: Asia Pacific - Drug-Eluting Stents Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 55: Asia Pacific - Drug-Eluting Stents Market Attractiveness Analysis, By Application, 2025-2035
  • Figure 56: Asia Pacific - Drug-Eluting Stents Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 57: Asia Pacific - Drug-Eluting Stents Market Attractiveness Analysis, By End-user, 2025-2035
  • Figure 58: Latin America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 59: Latin America - Drug-Eluting Stents Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 60: Latin America - Drug-Eluting Stents Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 61: Latin America - Drug-Eluting Stents Market Value Share Analysis, By Material, 2024 and 2035
  • Figure 62: Latin America - Drug-Eluting Stents Market Attractiveness Analysis, By Material, 2025-2035
  • Figure 63: Latin America - Drug-Eluting Stents Market Value Share Analysis, By Drug, 2024 and 2035
  • Figure 64: Latin America - Drug-Eluting Stents Market Attractiveness Analysis, By Drug, 2025-2035
  • Figure 65: Latin America - Drug-Eluting Stents Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 66: Latin America - Drug-Eluting Stents Market Attractiveness Analysis, By Application, 2025-2035
  • Figure 67: Latin America - Drug-Eluting Stents Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 68: Latin America - Drug-Eluting Stents Market Attractiveness Analysis, By End-user, 2025-2035
  • Figure 69: Middle East & Africa - Drug-Eluting Stents Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 70: Middle East & Africa - Drug-Eluting Stents Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 71: Middle East & Africa - Drug-Eluting Stents Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
  • Figure 72: Middle East & Africa - Drug-Eluting Stents Market Value Share Analysis, By Material, 2024 and 2035
  • Figure 73: Middle East & Africa - Drug-Eluting Stents Market Attractiveness Analysis, By Material, 2025-2035
  • Figure 74: Middle East & Africa - Drug-Eluting Stents Market Value Share Analysis, By Drug, 2024 and 2035
  • Figure 75: Middle East & Africa - Drug-Eluting Stents Market Attractiveness Analysis, By Drug, 2025-2035
  • Figure 76: Middle East & Africa - Drug-Eluting Stents Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 77: Middle East & Africa - Drug-Eluting Stents Market Attractiveness Analysis, By Application, 2025-2035
  • Figure 78: Middle East & Africa - Drug-Eluting Stents Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 79: Middle East & Africa - Drug-Eluting Stents Market Attractiveness Analysis, By End-user, 2025-2035